CARVER JENNIFER 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Jan 17, 2019
Insider Transaction Report
Form 4
CARVER JENNIFER
Sr. Vice President, Operations
Transactions
- Award
Stock Option (Right to Buy)
2019-01-15+213→ 213 totalExercise: $6.75Exp: 2029-01-15→ Common Stock (213 underlying) - Award
Common Stock
2019-01-15$5.74/sh+213$1,223→ 12,329 total
Footnotes (2)
- [F1]These shares were acquired on 01/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.